GNPX

SEC filing GNPX Reports Positive Clinical Data for Reqorsa Gene Therapy, Biomarkers Trop-2 and PTEN Correlate with Prolonged PFS in NSCLC Patients

7d ago

SEC filing GNPX Press Release: PM Gene Therapy Reverses Hyperglycemia in T2D Mice, 4-Week Complete Rescue, Endoscopic Delivery Potential

35d ago

Insider trade Sale by Brent M Longnecker

47d ago

Scanner Unusual buy pressure (3.3x avg, 62% up-volume, +17.9% / +0.33 intraday, above VWAP)

99d ago

SEC filing GNPX Receives Favorable Patent Decisions in Japan and Europe for REQORSA Gene Therapy in Cancer Treatment Combinations

99d ago

SEC filing GNPX Announces IP Australia Patent Acceptance for REQORSA Gene Therapy Combination, Expands Acclaim-3 Clinical Trial Sites

112d ago

News Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies

147d ago